Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MURATA, AUSTIN | 1 | 60.3% | +20.5% |
| KARUNASENA, ENUSHA | 1 | — | — |
| HOFFMAN, SUSAN COE | 1 | 54.1% | +25.6% |
| CHEN, CATHERYNE | 1 | 37.4% | +18.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18173316 | PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD CONTAINING EXTRACT OF FRUITING BODY OF GANODERMA LUCIDUM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF THROMBOSIS | HOFFMAN, SUSAN COE | 98d overdue |
| 18969718 | METHOD FOR FORMING ELECTROLESS PLATING ELECTRODE THROUGH SELECTIVE CROSS-LINKING LAYER FORMATION USING LASER | MURATA, AUSTIN | 14d |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 50d |
| Art Unit | Apps |
|---|---|
| 1655 | 2 |
| 1712 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18969718 | METHOD FOR FORMING ELECTROLESS PLATING ELECTRODE THROUGH SELECTIVE CROSS-LINKING LAYER FORMATION USING LASER | MURATA, AUSTIN | 1712 | §103 | Non-Final OA | 14d | Pending | Dec 05, 2024 |
| 18485314 | NOVEL BACILLUS VELEZENSIS GYUN-1190 STRAIN AND USE THEREOF | KARUNASENA, ENUSHA | 1653 | §103 | Non-Final OA | 19d overdue | Pending | Oct 12, 2023 |
| 18173316 | PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD CONTAINING EXTRACT OF FRUITING BODY OF GANODERMA LUCIDUM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF THROMBOSIS | HOFFMAN, SUSAN COE | 1655 | §103 | Final Rejection | 98d overdue | Pending | Feb 23, 2023 |
| 18171670 | IMMUNITY-ENHANCING COMPOSITION CONTAINING SYNEILESIS PALMATA EXTRACT AS ACTIVE INGREDIENT | CHEN, CATHERYNE | 1655 | §103 | Final Rejection | 50d | Pending | Feb 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial